Golden Genesis

Golden Genesis is a biotechnology firm based in Taiwan that focuses on the intersection of regenerative medicine and botanical therapeutics. The company is best known for its proprietary product, G-Nii, a fermented soy extract that has been studied in clinical settings for its immunomodulatory effects and its role in supporting patients undergoing cancer treatment. In addition to its botanical research, Golden Genesis provides stem cell banking services and is actively developing cell-based therapies utilizing mesenchymal stem cells derived from umbilical cord tissue. Their business strategy combines the commercialization of high-end nutraceuticals with a long-term commitment to clinical-stage drug development. The company aims to address unmet needs in oncology, immunology, and age-related health through innovative biological platforms.